site stats

Crxt market cap

WebFeb 10, 2024 · Market Average Movement. 6.3%. 10% most volatile stocks in US Market. 17.0%. 10% least volatile stocks in US Market. 2.7%. Stable Share Price: CRXT.Q is … WebNov 5, 2024 · It has a market capitalization of US$116m, which means it wouldn't have the attention of many institutional investors. ... NasdaqGM:CRXT Ownership Breakdown November 5th 2024

Clarus Therapeutics Holdings Inc (CRXT) Message Board - InvestorsHub

WebMarket Capitalization: EPS-$1.16: Price to Book-0.01: Revenue Per Employee: N/A: Enterprise Value/EBITDA-0.96: No CRXTQ news at the moment. Latest CRXTQ News. … WebFind the latest POINT Biopharma Global Inc. (PNT) stock quote, history, news and other vital information to help you with your stock trading and investing. arena dubai mall https://aceautophx.com

CRXTQ Clarus Therapeutics Holdings, Inc. - SeekingAlpha

WebFeb 7, 2024 · CRXT Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Clarus Therapeutics Holdings, Inc... Toggle navigation Toggle navigation. Toggle … WebAbout Clarus Therapeutics Holdings (CRXT) Clarus Therapeutics Holdings, Inc. is a pharmaceutical company, which engages in developing androgen and metabolic … WebMarket Cap: $ 0.00: About Clarus Therapeutics Holdings, Inc. Statistics. The CRXT stock price is closed at $ 0.047500 (44M shares outstanding). The CRXT is trading on … bakugan magnus meme

Buy Clarus Therapeutics Holdings Stock CRXT Stock Price Today …

Category:Stock (OTC:CRXT), Quotes and News Summary - Benzinga

Tags:Crxt market cap

Crxt market cap

CRXTQ Clarus Therapeutics Holdings, Inc. - SeekingAlpha

Web101 rows · Top cryptocurrency prices and charts, listed by market capitalization. Free access to current and historic data for Bitcoin and thousands of altcoins. Cryptos: 23,368 Exchanges: 611 Market Cap: … WebApr 25, 2024 · DNY59/E+ via Getty Images. Clarus Therapeutics Holdings (NASDAQ:CRXT) is down 22% in premarket trading after the company filed for an equity …

Crxt market cap

Did you know?

WebENSC 1D Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on proprietary technology platforms to develop safer prescription drugs. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms, are in the process of developing a new class of pow Ensysce Biosciences, Inc. is a clinical-stage … WebApr 11, 2024 · Crane NXT, Co. has a market cap or net worth of $4.51 billion as of April 12, 2024. Market Cap 4.51B. Enterprise Value 5.10B. 1-Year Change n/a. Ranking # 1250. …

WebClarus Therapeutics stock quote and CRXT charts. Latest stock price today and the US's most active stock market forums. ... Market Cap Shares in Issue Float Revenue … WebAbout Clarus Therapeutics Holdings (CRXT) Clarus Therapeutics Holdings, Inc. is a pharmaceutical company, which engages in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company was founded in 2004 and is headquartered in Los Angeles, CA. Market cap. $72.8k. Today's …

WebThe latest price target for . (OTC: CRXT) was reported by Needham on Tuesday, August 23, 2024.The analyst firm set a price target for 0.00 expecting CRXT to fall to within 12 … WebMarket Cap is a widely used stock evaluation measure. Find the latest Market Cap for NA (CRXT)

WebClarus Therapeutics Hldgs Inc (CRXT) Clarus Therapeutics Hldgs Inc (CRXT) [[ item.lastPrice ]] ... Market Cap: capitalization or market value of a stock is simply the …

WebAug 31, 2024 · In the recent session, the day high for CRXT stock was $0.075 while the low for CRXT stock touched on the day was $0.051. What is the market cap of CRXT … bakugan magnus secret crushWebTORONTO, March 08, 2024--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics® is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in a virtual fireside chat at the Oppenheimer 33rd Annual Healthcare ... arena dudu camargo menuWebApr 9, 2024 · Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. the company’s first commercial product is JATENZO. It is headquartered in Northbrook, IL. arena dukatia cityWebJul 16, 2024 · Market Cap Calculator; Options Profit Calculator; Stock Average Calculator; Stock Split Calculator; Stock Profit Calculator; Research Tools. Compare Stocks; Live … bakugan lupta finalaWebAbout Clarus Therapeutics Holdings Inc. 555 SKOKIE BOULEVARD SUITE 340, NORTHBROOK, Illinois, 60062, United States +1 847 562-4300. Clarus Therapeutics Holdings Inc is a pharmaceutical company ... Find the latest SEC Filings data for Clarus Therapeutics Holdings Inc. (CRXT) at … Find the latest Institutional Holdings data for Clarus Therapeutics Holdings Inc. … arena dudu barWeb52 Week Low Date 03/30/23. Market Cap 34.634M. Shares Out 346.34B. 10 Day Average Volume 360.39M. Dividend -. Dividend Yield -. Beta 1.58. YTD % Change -50. bakugan maker gameWebFind the latest Revelation Biosciences, Inc. (REVB) stock quote, history, news and other vital information to help you with your stock trading and investing. arena dudu